-
Mashup Score: 0Highlights from ESMO Asia 2022 in HCC - 1 year(s) ago
Stephen L. Chan, MBBS (HK), MRCP (UK), FHKCP, FHKAM (Medicine), FRCP (Edin), FRCP (Lond), Chinese University of Hong Kong, Hong…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Identifying patients with HCC who will respond best to IO - 1 year(s) ago
Stephen L. Chan, MBBS (HK), MRCP (UK), FHKCP, FHKAM (Medicine), FRCP (Edin), FRCP (Lond), Chinese University of Hong Kong, Hong…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Domenica Lorusso, MD, PhD, Catholic University of Rome and Fondazione Policlinico Gemelli IRCCS, Rome, Italy, discusses a variety of possible…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Unmet needs in immunotherapy for hepatocellular carcinoma - 1 year(s) ago
Mara Persano, MD, University Of Cagliari, Cagliari, Italy, discusses the current unmet needs in the field of immunotherapy (IO) for…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0HIMALAYA trial: Asian subgroup results - 1 year(s) ago
Stephen L. Chan, MBBS (HK), MRCP (UK), FHKCP, FHKAM (Medicine), FRCP (Edin), FRCP (Lond), Chinese University of Hong Kong, Hong…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Stephen L. Chan, MBBS (HK), MRCP (UK), FHKCP, FHKAM (Medicine), FRCP (Edin), FRCP (Lond), Chinese University of Hong Kong, Hong…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Domenica Lorusso, MD, PhD, Catholic University of Rome and Fondazione Policlinico Gemelli IRCCS, Rome, Italy, talks on the latest clinical…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Real-world outcomes of patients with HCC treated with lenvatinib vs. atezolizumab plus bevacizumab - 1 year(s) ago
Mara Persano, MD, University Of Cagliari, Cagliari, Italy, discusses a real-world study comparing first-line lenvatinib vs. atezolizumab plus bevacizumab for…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Improving outcomes for patients with head and neck cancer - 1 year(s) ago
Avinash Khadela, PhD, L.M. College Of Pharmacy, Ahmedabad, India, discusses the key unmet needs for patients with head and neck…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Epidemiology of rare cancers in Asia and Europe - 1 year(s) ago
Annalisa Trama, MD, PhD, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, explains that the incidence of rare cancers is…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
🎥 @StephenLChan1 of @CUHKMedicine talks on highlights from ESMO Asia 2022 in HCC Watch: 👉https://t.co/UriFJpo4vN👈 #ESMOAsia22 @myESMO #HPBCsm